Inventor · disambiguated record
Ashok Vinayak Purandare
Also filed as: PURANDARE ASHOK V · PURANDARE ASHOK VINAYAK
19 granted patents·7 pending applications·112 citations·filing 2001–2024
93Inventor score
Top patents by PatentIndex Score
26 records- 0194US9273057B2Imidazotriazinecarbonitriles useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Mar 1, 2016·29 cites·15 claims
- 0289US7531539B2Pyrrolotriazine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted May 12, 2009·18 cites·10 claims
- 0388US8202881B2JAK2 inhibitors and their use for the treatment of myeloproliferative diseases and cancerPURANDARE ASHOK V·Filed 2010·Granted Jun 19, 2012·20 cites·14 claims
- 0485US9822103B2Inhibitors of lysine methyl transferaseBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Nov 21, 2017·8 cites·7 claims
- 0583US11548870B2Compounds useful as inhibitors of helios proteinBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Jan 10, 2023·1 cites·12 claims
- 0683US8815840B2Carbazole and carboline kinase inhibitorsPURANDARE ASHOK VINAYAK·Filed 2009·Granted Aug 26, 2014·5 cites·6 claims
- 0783US8673933B2JAK2 inhibitors and their use for the treatment of myeloproliferative diseases and cancerPURANDARE ASHOK V·Filed 2012·Granted Mar 18, 2014·9 cites·3 claims
- 0881US9738630B2Inhibitors of lysine methyl transferaseBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Aug 22, 2017·2 cites·2 claims
- 0979US9556178B2Imidazotriazinecarbonitriles useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jan 31, 2017·3 cites·7 claims
- 1079US8940736B2Imidazotriazinecarbonitriles useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jan 27, 2015·3 cites·19 claims
- 1179US8445676B2Pyrrolotriazine kinase inhibitorsPURANDARE ASHOK VINAYAK·Filed 2009·Granted May 21, 2013·5 cites·10 claims
- 1278US10053454B2Carbazole compounds useful as bromodomain inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Aug 21, 2018·3 cites·5 claims
- 1377US12331045B2Substituted phenyl oxazolone compoundsBRISTOL MYERS SQUIBB CO·Filed 2024·Granted Jun 17, 2025·0 cites·27 claims
- 1467US7202249B2Antagonists of chemokine receptorsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Apr 10, 2007·3 cites·5 claims
- 1567US6630469B25-HT7 receptor antagonistsBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Oct 7, 2003·3 cites·18 claims
- 1659US2025346574A1Pyridinyl substituted oxoisoindoline compounds for the treatment of cancerBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 1753US9593116B2Crystalline forms of N,N-dicyclopropyl-4-(1,5-dimethyl-1H-pyrazol-3-ylamino)-6-ethyl-1-methyl-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine-7-carboxamide for the treatment of myeloproliferative disordersBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Mar 14, 2017·0 cites·8 claims
- 1853US2016108050A1Imidazotriazinecarbonitriles useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 1950US2023295087A1AGONISTS OF ROR GAMMAtBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 2049US11485741B2Macrocyclic toll-like receptor 7 (TLR7) agonistsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Nov 1, 2022·0 cites·18 claims
- 2149US2004171556A1Methods for inhibiting proteasomeFiled 2004·Application pending·0 cites
- 2249US2022306630A1AGONISTS OF ROR GAMMAtBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 2348US10196387B2Carbazole compounds useful as bromodomain inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Feb 5, 2019·0 cites·5 claims
- 2447US10550125B2Prodrugs of imidazotriazine compounds as CK2 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Feb 4, 2020·0 cites·5 claims
- 2544US2007060589A1Inhibitors of protein arginine methyl transferasesPURANDARE ASHOK V·Filed 2005·Application pending·0 cites
- 2644US2006235037A1Heterocyclic inhibitors of protein arginine methyl transferasesPURANDARE ASHOK V·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ashok Vinayak Purandare files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →